WallStreetZenWallStreetZen

NASDAQ: TELA
Tela Bio Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for TELA

Based on 3 analysts offering 12 month price targets for Tela Bio Inc

Min Forecast
$2.00-1.96%
Avg Forecast
$5.33+161.42%
Max Forecast
$7.00+243.14%

Should I buy or sell TELA stock?

Based on 3 analysts offering ratings for Tela Bio Inc.

Buy
Strong Buy
1 analysts 33.33%
Buy
1 analysts 33.33%
Hold
1 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their TELA stock forecasts and price targets.

TELA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-03-21
lockedlocked$00.00+00.00%2025-03-21
lockedlocked$00.00+00.00%2025-03-21

1 of 1

Forecast return on equity

Is TELA forecast to generate an efficient return?

Company
4.37%
Industry
22.93%
Market
66.99%
TELA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is TELA forecast to generate an efficient return on assets?

Company
1.02%
Industry
12.07%
TELA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

TELA earnings per share forecast

What is TELA's earnings per share in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
-$0.72
Avg 2 year Forecast
-$0.35
Avg 3 year Forecast
$0.02

TELA revenue forecast

What is TELA's revenue in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
$86.1M+20.9%
Avg 2 year Forecast
$106.5M+49.54%
Avg 3 year Forecast
$121.1M+70.04%
TELA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

TELA revenue growth forecast

How is TELA forecast to perform vs Medical Devices companies and vs the US market?

Company
21.33%
Industry
8.25%
Market
10.36%
TELA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
TELA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

TELA vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
TELA$2.04$5.33+161.42%Buy
QIPT$1.78$2.85+60.11%Buy
SRTS$4.66$11.67+150.36%Strong Buy
ELUT$2.09$8.00+282.78%Strong Buy
APYX$2.29N/AN/A
View Top Medical Device Stocks

Tela Bio Stock Forecast FAQ

Is Tela Bio Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: TELA) stock is to Buy TELA stock.

Out of 3 analysts, 1 (33.33%) are recommending TELA as a Strong Buy, 1 (33.33%) are recommending TELA as a Buy, 1 (33.33%) are recommending TELA as a Hold, 0 (0%) are recommending TELA as a Sell, and 0 (0%) are recommending TELA as a Strong Sell.

If you're new to stock investing, here's how to buy Tela Bio stock.

What is TELA's earnings growth forecast for 2025-2027?

(NASDAQ: TELA) Tela Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 20.97%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 20.08%.

Tela Bio's earnings in 2025 is -$43,444,000.On average, 2 Wall Street analysts forecast TELA's earnings for 2025 to be -$28,281,817, with the lowest TELA earnings forecast at -$30,061,792, and the highest TELA earnings forecast at -$26,501,843. On average, 2 Wall Street analysts forecast TELA's earnings for 2026 to be -$13,844,246, with the lowest TELA earnings forecast at -$20,173,044, and the highest TELA earnings forecast at -$7,515,448.

In 2027, TELA is forecast to generate $791,100 in earnings, with the lowest earnings forecast at $791,100 and the highest earnings forecast at $791,100.

What is TELA's revenue growth forecast for 2025-2027?

(NASDAQ: TELA) Tela Bio's forecast annual revenue growth rate of 21.33% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.25%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.36%.

Tela Bio's revenue in 2025 is $71,217,000.On average, 2 Wall Street analysts forecast TELA's revenue for 2025 to be $3,405,684,553, with the lowest TELA revenue forecast at $3,385,907,058, and the highest TELA revenue forecast at $3,425,462,047. On average, 2 Wall Street analysts forecast TELA's revenue for 2026 to be $4,212,606,329, with the lowest TELA revenue forecast at $4,070,208,368, and the highest TELA revenue forecast at $4,355,004,289.

In 2027, TELA is forecast to generate $4,790,109,168 in revenue, with the lowest revenue forecast at $4,790,109,168 and the highest revenue forecast at $4,790,109,168.

What is TELA's forecast return on assets (ROA) for 2025-2027?

(NASDAQ: TELA) forecast ROA is 1.02%, which is lower than the forecast US Medical Devices industry average of 12.07%.

What is TELA's Price Target?

According to 3 Wall Street analysts that have issued a 1 year TELA price target, the average TELA price target is $5.33, with the highest TELA stock price forecast at $7.00 and the lowest TELA stock price forecast at $2.00.

On average, Wall Street analysts predict that Tela Bio's share price could reach $5.33 by Mar 21, 2026. The average Tela Bio stock price prediction forecasts a potential upside of 161.42% from the current TELA share price of $2.04.

What is TELA's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: TELA) Tela Bio's current Earnings Per Share (EPS) is -$1.35. On average, analysts forecast that TELA's EPS will be -$0.72 for 2025, with the lowest EPS forecast at -$0.76, and the highest EPS forecast at -$0.67. On average, analysts forecast that TELA's EPS will be -$0.35 for 2026, with the lowest EPS forecast at -$0.51, and the highest EPS forecast at -$0.19. In 2027, TELA's EPS is forecast to hit $0.02 (min: $0.02, max: $0.02).

What is TELA's forecast return on equity (ROE) for 2025-2027?

(NASDAQ: TELA) forecast ROE is 4.37%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.